Koninklijke Philips NV vs Schlumberger NV — how do they compare? Koninklijke Philips NV trades at $24.22 (market cap $23.52B), while Schlumberger NV trades at $48.93 (market cap $72.69B). The key difference: Schlumberger NV is far larger — about 3.1× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Schlumberger NV for 99 Days on average.
| PHG | SLB | |
|---|---|---|
Market Cap | $23.52B | $72.69B |
Volume | 1,635,069 | 16,228,451 |
Sector | Health | Energy |
52-Week High | $32.91 | $60.10 |
52-Week Low | $23.81 | $31.72 |
Typical Hold Time | 84 Days | 99 Days |
Enterprise Value | $29.87B | $81.42B |
Dividend Yield | 4.17% | 2.41% |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.24, up 0.62% today, amid a bearish technical signal from moving averages. The company has beaten EPS estimates for three consecutive quarters, with Q3 2026 results pending. Recent financials show a return to profitability in 2025 with net income of $895 million, while cash flow from operations remains positive at $1.17 billion. Key developments include new product launches in healthcare imaging and a $33.7 million ARPA-H award for AI-enabled stroke care.
The outlook is mixed: strong earnings momentum and solid profitability metrics support upside, but technical weakness and a high 'Hold' analyst consensus suggest near-term caution. Risks include competitive pressures and debt levels, though institutional buying activity indicates underlying confidence.
SLB trades at $48.95, up 2.06% today, but technical indicators signal a bearish trend with key support at $48. The company reported revenue of $35.71B in 2025 with a net income margin of 8.53%, though margins have softened from prior years. Recent contract wins in Oman and Mozambique bolster long-term revenue visibility, while analyst consensus remains strongly bullish with an average price target of $64.58.
The stock presents a value opportunity given analyst optimism and strategic contract expansions, but faces headwinds from declining profit margins and bearish technical momentum. Earnings beats in recent quarters support fundamental strength, yet investors must weigh execution risks against the potential for significant upside relative to the current price.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →